SCHEMBL5380106

SCHEMBL5380106

CCOC(OCC)c1ccccc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
GABRA1 P14867 1/20 0.50
GABRB2 P47870 1/20 0.50
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
POLB P06746 3/20 0.41
CA2 P00918 3/20 0.38
CA12 O43570 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA1 P00915 2/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
GLA P06280 1/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5383313 0.84 BCHE (0.47) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL6242574 0.82 CA1 (0.43) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL2219317 0.82 TSHR (0.59) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL6238347 0.81 TSHR (0.40) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL28290505 0.80 TSHR (0.52) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL22444462 0.80 TSHR (0.57) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL22444530 0.77 TSHR (0.48) TSHRGABRA1GABRB2PTPN2PTPN1
SCHEMBL1956043 0.77 TSHR (0.48) TSHRGABRA1GABRB2POLBL3MBTL1
SCHEMBL5386636 0.77 IDO1 (0.46) TSHRL3MBTL1
SCHEMBL699772 0.77 ALDH1A1 (0.38) TSHRL3MBTL1GLAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174853-A1 QUANTUM DOT COMPOSITION, DISPLAY APPARATUS AND MANUFACTURING METHOD OF THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed
US-20230174853-A1 QUANTUM DOT COMPOSITION, DISPLAY APPARATUS AND MANUFACTURING METHOD OF THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed
CN-104478875-B Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) 麦迪韦逊科技有限公司 2017-04-12 CN disclosed
US-7300472-B2 Agents for coloring fibers containing keratin HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-11-27 US disclosed
US-20070000074-A1 Agents for coloring fibers containing keratin HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2007-01-04 US disclosed
EP-1534227-B1 AGENTS USED FOR DYEING KERATINOUS FIBERS HENKEL KGAA (DE) 2006-12-27 EP disclosed
EP-1715839-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN, COMPRISING HETEROCYCLIC ENAMINES AND REACTIVE CARBONYL COMPOUNDS AND/OR REACTION PRODUCTS THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 2006-11-02 EP disclosed
US-7105032-B2 Agents used for dyeing keratinous fibers HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2006-09-12 US disclosed
CN-1681470-A Agent for dyeing keratinous fibres HENKEL KGAA (DE) 2005-10-12 CN disclosed
WO-2005063178-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN, COMPRISING HETEROCYCLIC ENAMINES AND REACTIVE CARBONYL COMPOUNDS AND/OR REACTION PRODUCTS THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-07-14 WO disclosed
EP-1534227-A1 AGENTS USED FOR DYEING KERATINOUS FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-06-01 EP disclosed
WO-2004022016-A1 AGENTS USED FOR DYEING KERATINOUS FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-03-18 WO disclosed
US-4853383-A β-blocking substituted imidazoles MERCK & CO., INC. (US) 1989-08-01 US disclosed
US-4642311-A β-adrenergic blocking imidazolylphenoxy propanolamines MERCK & CO., INC. (US) 1987-02-10 US disclosed
US-4567276-A HYPOTENSIVE AGENTS, ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1986-01-28 US disclosed
US-4440774-A ANTIHYPERTENSIVE AGENTS AND B-ANDRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1984-04-03 US disclosed
US-4199580-A HYPOTENSIVE AGENTS AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1980-04-22 US disclosed
US-4134983-A HYPOTENSIVE, ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1979-01-16 US disclosed
US-3944674-A Combating insects with o dimethoxymethylphenyl-N-methylcarbamate CIBA-GEIGY AG (CH) 1976-03-16 US disclosed
US-3933858-A INSECTICIDES CIBA-GEIGY AG (CH) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070000074-A1 Agents for coloring fibers containing keratin KRT18, COL1A1, CYC1 TSHR 4090/4885GABRA1 4732/4885GABRB2 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.